Collectively, these biomarkers capture the pathological continuum from nuclear DNA damage (8‐OHdG) and lipid peroxidation (Ox‐LDL) to endothelial dysfunction (ICAM‐1/E‐selectin), providing a comprehensive insight into preclinical vascular pathology in high‐risk populations. This evidence concerns the gene ICAM1 and endothelial dysfunction.